At AstraZeneca, Computational Pathology is part of the Oncology Translational Medicine department within our Oncology R&D organisation. AstraZeneca’s vision in Oncology is to push the boundaries of science to change the practice of medicine, transform the lives of patients living with cancer, and to ultimately eliminate cancer as a cause of death. The Computational Pathology team was established with the acquisition of Definiens. At our state of the art site in Munich, we are changing the wa...